•  
  •  
  •  
  •  

2025-10-02 16:07:24

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  SumitomoChemicalIndia

Stock Report

  • Sumitomo Chemical India Ltd Q1 FY2024-25 consolidated PAT climbs to Rs. 126.67 crores
  • Sumitomo Chemical India Ltd posts lower consolidated PAT of Rs. 54.71 crores in Q3 FY2024
  • Sumitomo Chemical India Ltd Q1 FY2024 consolidated net profit drops to Rs. 61.67 crores
  • Sumitomo Chemical India Ltd declares dividend of Rs. 1.20
  • Sumitomo Chemical India Ltd Q4 FY23 consolidated net profit lower at Rs. 72.12 crores
  • GPCB revokes closure order of Sumitomo Chemical India Ltd's Bhavnagar site for 3 months
  • GPCB asks Sumitomo Chemical India Ltd to close operations at Bhavnagar site
  • Sumitomo Chemical India Limited - Accident at Bhavnagar Site
  • Sumitomo Chemical India Ltd Q3 FY2022-23 consolidated profit at Rs. 90.48 crores
  • Sumitomo Chemical India Ltd Q2 FY2023 consolidated PAT climbs to Rs. 201.46 crores
  • Sumitomo Chemical India Ltd Q1FY23 consolidated profit climbs to Rs. 138.13 crores
  • Sumitomo Chemical India Ltd declares dividend of Rs. 1
  • Sumitomo Chemical India Ltd Q4FY22 consolidated PAT slips QOQ to Rs. 74.65 crores
  • Sumitomo Chemical India Q3FY22 consolidated net profit declines QoQ to Rs. 88.93 crores
  • Sumitomo Chemical India Ltd posts consolidated Q2FY22 net profit of Rs. 154.21 crore

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024